LISA ERTMAN: Open Payments
NPI 1508573288 · FAIRMONT, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 11 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $144 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| Amgen Inc. | 1 | $13 |
| Itamar Medical Inc | 1 | $10 |
Products named: CAPLYTA, NEXLETOL, KEVEYIS, ZEPBOUND, TRINTELLIX, VRAYLAR, OTEZLA, WatchPATONE.
Industry payments across MN — which companies pay providers there.
